3a-(2-Chlorophenyl)-3a,4,5,6-tetrahydrobenzo[d]oxazol-2(3H)-one, 5mg

5-Bromo-2-methyl-7-azaindole, 95.0%, 25g

6,7-Dihydropyrazino[2,3-d]pyridazine-5,8-dione, 1g

Fmoc-Gly-OH, 98%, 25g

(3-propylpiperidin-3-yl)methanol, 95.0%, 5g

(S)-2-Amino-3-(thiophen-2-yl)propanoic acid, 95.0%, 250mg

4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide hydrochloride, 95.0%, 250mg

N-Methoxy-N-methyldifluoroacetamide, 98.0%, 10g

Finasteride, 99.0%, 5g

2-Methoxy-4-methyl-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 250mg

Unité de filtration Rapid-Flow avec membrane PES Taille des pores 0,45 μm, 150 ml, 150 ml, 50 mm, 12 pièce(s)

ISOORIENTIN, 99%, 10mg

[(2-chloro-6-fluorophenyl)methyl](2-methylpropyl)amine, 95.0%, 2g